Hummelgaard, Sandra
Kresse, Jean-Claude
Jensen, Michael Schou
Glerup, Simon
Weyer, Kathrin
Funding for this research was provided by:
Danish Cardiovascular Academy (PhD2021003-DCA)
Danish Council for Independent Research (DFF 9060-00046B)
Augustinus Fonden (21-1561)
Article History
Received: 17 December 2024
Revised: 7 February 2025
Accepted: 10 February 2025
First Online: 18 February 2025
Declarations
:
: SH and SG have significant financial interest in companies involved in the development of PCSK9 inhibitors. The remaining authors declare no competing interests.